Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antonescu, C. R.
Right arrow Articles by Ladanyi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antonescu, C. R.
Right arrow Articles by Ladanyi, M.
Clinical Cancer Research Vol. 6, 2788-2793, July 2000
© 2000 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Monoclonality of Multifocal Myxoid Liposarcoma: Confirmation by Analysis of TLS-CHOP or EWS-CHOP Rearrangements

Cristina R. Antonescu, Abul Elahi, John H. Healey, Murray F. Brennan, Man Yee Lui, Jonathan Lewis, Suresh C. Jhanwar, James M. Woodruff and Marc Ladanyi1

Departments of Pathology [C. R. A., M. Y. L., J. M. W., M. L.], Human Genetics [A. E., S. C. J., M. L.], and Surgery [J. H. H., M. F. B., J. L.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Multifocal presentation, defined as the presence of tumor at two or more anatomically separate sites, before the manifestation of disease in sites where sarcomas usually metastasize (e.g., lungs) occurs in about 1% of extremity soft tissue sarcomas (STSs). Debate still persists whether multifocal STSs represent an unusual pattern of metastasis or multiple separate primary tumors. Among STSs with multifocal presentation, myxoid liposarcoma is the predominant histological type. This subtype of liposarcoma contains the specific t(12;16) chromosomal translocation, which results in rearrangement of the TLS and CHOP genes that is clone specific at the DNA level. We, therefore, sought to address the question of clonality by molecular analysis in six patients who presented with either synchronous or metachronous multifocal myxoid liposarcoma. In all six cases, adequate frozen tumor was available for DNA extraction from at least two distinct anatomical sites. Southern blot analysis using CHOP, TLS, and EWS cDNA probes was performed on genomic DNA. Five cases contained a TLS-CHOP rearrangement, and one case had the variant EWS-CHOP fusion (seen in <5% of cases). The size of the rearranged CHOP fragment differed among the six patients, as expected, but was identical in all anatomically separate tumor samples from each patient. Likewise, the sizes of the rearranged bands observed with either the TLS or EWS probes supported the monoclonality of all cases. Our results confirm the monoclonal origin of multifocal myxoid liposarcoma, establishing the metastatic nature of distant soft tissue lesions in these cases. It remains unclear whether this unusual pattern of metastasis represents an intrinsic property of this subset of myxoid liposarcoma or merely a rare chance occurrence. The clinical outcomes observed in this small series suggest that the prognosis of multifocal myxoid liposarcoma is poor, regardless of its often bland or "low-grade" histological appearance.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
J. H. Schwab, P. Boland, T. Guo, M. F. Brennan, S. Singer, J. H. Healey, and C. R. Antonescu
Skeletal Metastases in Myxoid Liposarcoma: An Unusual Pattern of Distant Spread
Ann. Surg. Oncol., April 1, 2007; 14(4): 1507 - 1514.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
N. C. Birch, C. R. Antonescu, M. Nelson, L. Sarran, J. R. Neff, T. Seemayer, and J. A. Bridge
Inconspicuous Insertion 22;12 in Myxoid/Round Cell Liposarcoma Accompanied by the Secondary Structural Abnormality der(16)t(1;16)
J. Mol. Diagn., August 1, 2003; 5(3): 191 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. Hosaka, Y. Nakashima, K. Kusuzaki, H. Murata, T. Nakayama, T. Nakamata, T. Aoyama, T. Okamoto, K. Nishijo, N. Araki, et al.
A Novel Type of EWS-CHOP Fusion Gene in Two Cases of Myxoid Liposarcoma
J. Mol. Diagn., August 1, 2002; 4(3): 164 - 171.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. R. Antonescu, S. J. Tschernyavsky, R. Decuseara, D. H. Leung, J. M. Woodruff, M. F. Brennan, J. A. Bridge, J. R. Neff, J. R. Goldblum, and M. Ladanyi
Prognostic Impact of P53 Status, TLS-CHOP Fusion Transcript Structure, and Histological Grade in Myxoid Liposarcoma: A Molecular and Clinicopathologic Study of 82 Cases
Clin. Cancer Res., December 1, 2001; 7(12): 3977 - 3987.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2000 by the American Association for Cancer Research.